Skip to Content
Biotechnology

The health sector is being struck by cyber-espionage

Security researchers say a group of hackers has been targeting firms related to health care in order to steal intellectual property.

The news:  Symantec reports that it’s observed a hacking team, called Orangeworm, compromise the systems of pharmaceutical firms, medical-device manufacturers, health-care providers, and even IT companies working with medical organizations. Victims don’t appear to have been chosen at random but “carefully and deliberately.”

What they’re doing: The point to these hacks doesn’t appear to be theft of patient data like insurance records. Instead, the hackers seem to be looking for intellectual property—such as details of drug manufacturing, or technical details about expensive medical imaging systems.

Who’s doing it? That remains unclear. Symantec says it doesn’t appear to be the work of a nation-state, but rather “an individual or a small group of individuals.” But so far there are no clues within the attacks to reveal who is in the group, or where it’s based.

Why it matters: It’s unusual that a small band of hackers would go after intellectual property in this way, rather than personal details that can be easily sold for cash. That raises questions about who is paying them to gather the information. But the group is clearly doing its job well: it’s attacked over 100 organizations since 2015.

Deep Dive

Biotechnology

The first babies conceived with a sperm-injecting robot have been born

Meet the startups trying to engineer a desktop fertility machine.

Doctors have performed brain surgery on a fetus in one of the first operations of its kind

A baby girl who developed a life-threatening brain condition was successfully treated before she was born—and is now a healthy seven-week-old.

A brain implant changed her life. Then it was removed against her will.

Her case highlights why we need to enshrine neuro rights in law.

The FDA just approved rub-on gene therapy that helps “butterfly” children

Biotech companies are getting creative with how they deliver DNA fixes into people's bodies.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.